Sign in

CIK 0001735438

  • Non-accelerated filer
  • Smaller reporting company

MeiraGTx Holdings plc

Sign in to watch
Ticker
MGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
981448305
Phone
+1 646-860-7985
Business address
655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
  1. 4 Derivatives Options or other derivatives
  2. 4 Exercise or conversion Director acquired 75,000 shares (option exercise)
  3. 4 Planned sale CFO & COO sold 24,000 shares at $6.00 ($144,000)
  4. 4 Planned sale PRESIDENT & CEO sold 47,500 shares at $5.34 ($253,650)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 5,903 shares (to pay taxes)
  11. 4 Shares withheld for taxes GENERAL COUNSEL AND SECRETARY gave up 12,116 shares (to pay taxes)
  12. 4 Shares withheld for taxes CHIEF DEV. OFFICER gave up 23,500 shares (to pay taxes)
  13. 4 Shares withheld for taxes CFO & COO gave up 63,452 shares (to pay taxes)
  14. 4 Shares withheld for taxes PRESIDENT & CEO gave up 66,095 shares (to pay taxes)
  15. 4 Planned sale CFO & COO sold 24,000 shares at $6.29 ($150,960)
  16. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 15,149 shares (to pay taxes)
  17. 4 Shares withheld for taxes GENERAL COUNSEL AND SECRETARY gave up 2,909 shares (to pay taxes)
  18. 4 Shares withheld for taxes CHIEF DEV. OFFICER gave up 11,163 shares (to pay taxes)
  19. 4 Shares withheld for taxes CFO & COO gave up 13,219 shares (to pay taxes)
  20. 4 Shares withheld for taxes PRESIDENT & CEO gave up 15,863 shares (to pay taxes)

Page 4 of 13 · 260 filings